Liaoning Sibaide Medicine Technology Co., Ltd.

The purpose of this study is to study the single-dose and multiple-dose pharmacokinetic studies of Ozagrel Hydrochloride Tablets provided by Tongliao Huabang Pharmaceutical Co., Ltd. in healthy volunteers. By establishing the methodology of Ozagrel and its metabolites in blood samples and detecting plasma samples, the corresponding pharmacokinetic parameters are obtained to understand the dynamic changes of Ozagrel Hydrochloride Tablets in the human body and the accumulation in the body after multiple continuous administrations, so as to provide a basis for rational clinical drug use.